A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase
Jiankun Guan, Yuxin Wu, Xin Liu, Huimin Wang, Ningbing Ye, Zheng Li, Chen Xiao, Zhijie Zhang, Zifu Li, Xiangliang Yang
Topics & Concepts
Indoleamine 2,3-dioxygenaseCancer researchCancer stem cellProdrugTumor microenvironmentTriple-negative breast cancerImmunogenic cell deathImmune systemPaclitaxelStem cellChemistryCancerBiologyPharmacologyImmunologyMedicineImmunotherapyBreast cancerCell biologyInternal medicineBiochemistryTumor cellsTryptophanAmino acidTryptophan and brain disordersEpigenetics and DNA MethylationCancer, Stress, Anesthesia, and Immune Response